1024免费一级欧美片在线观看_久久免费精品视频互動交流_国国产无套粉嫩白浆在线_饥渴难耐的浪荡艳妇_亚洲国产日韩一区在线_欧美激情性爱吧_精品人妻少妇av嫩草_嗯啊不要视频_另类欧美亚洲综合_网友自拍亚洲无码另类

杭州昊鑫生物科技股份有限公司
網(wǎng)站標(biāo)題
搜索

取消

清空記錄

歷史記錄

清空記錄

歷史記錄

清空記錄

歷史記錄

杭州昊鑫生物科技股份有限公司
    當(dāng)前位置:
  • 首頁(yè)>
  • 產(chǎn)品中心>
  • MCE>
  • Vancomycin...

產(chǎn)品中心

Vancomycin hydrochloride (鹽酸萬(wàn)古霉素)

分享到微信

×
Vancomycin hydrochloride 是用于研究細(xì)菌感染 (bacterial) 的抗生素。 它通過(guò)抑制易感細(xì)菌的細(xì)胞壁合成的第二階段起作用。 Vancomycin hydrochloride 還改變細(xì)胞膜的滲透性并選擇性地抑制核糖核酸的合成。貨號(hào):HY-17362 ,CAS:1404-93-9
參數(shù)品牌:MCE
產(chǎn)品參數(shù)
品牌:MCE
型號(hào):HY-17362
起訂量:1
規(guī)格::250 mg
價(jià)格::¥500
我知道了
在線客服
產(chǎn)品詳情

Vancomycin hydrochloride (Synonyms: 鹽酸萬(wàn)古霉素)

Vancomycin hydrochloride 是用于研究細(xì)菌gan染 (bacterial) 的抗生su。 它通過(guò)抑制易感細(xì)菌的細(xì)胞壁合成的第二階段起作用。 Vancomycin hydrochloride 還改變細(xì)胞膜的滲透性并選擇性地抑制核糖核酸的合成。

生物活性

Vancomycin hydrochloride is an antibiotic for the treatment of bacterial infections. It acts by inhibiting the second stage of cell wall synthesis of susceptible bacteria. Vancomycin also alters the permeability of the cell membrane and selectively inhibits ribonucleic acid synthesis


IC50 & Target:Bacterial[1]


體外研究(In Vitro)

Vancomycin is a large glycopeptide compound with a molecular weight of 1450 Da[1]. Vancomycin is a unique glycopeptide structurally unrelated to any currently available antibiotic. It also has a unique mode of action inhibiting the second stage of cell wall synthesis of susceptible bacteria. Vancomycin is active against a large number of species of Gram-positive bacteria, such as Staphylococcus aureus, Staph. epidermidis, Str. agalactiae, Str. bovis, Str. mutans, viridans streptococci, enterococ


體內(nèi)研究(In Vivo)

Vancomycin is administered intravenously, with a standard infusion time of at least 1 h, to minimize infusion-related adverse effects. Subjects with normal creatinine clearance, vancomycin has an α-distribution phase of 30 min to 1 h and a β-elimination half-life of 6-12 h. The volume of distribution is 0.4–1 L/kg. The binding of vancomycin to protein ranges from 10% to 50%. Factors that affect the overall activity of vancomycin include its tissue distribution, inoculum size, and protein-binding effects[1]. Vancomycin treatment of infected mice is associated with improved clinical, diarrhea, and histopathology scores and survival during treatment[3].


分子量:1485.71


Formula:C66H76Cl3N9O24


CAS 號(hào):1404-93-9


中文名稱:鹽酸萬(wàn)古霉素


來(lái)源:Streptomyces orientalis


運(yùn)輸條件:Room temperature in continental US; may vary elsewhere.


儲(chǔ)存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


溶解性數(shù)據(jù)


H2O : 33.33 mg/mL (22.43 mM; Need ultrasonic)

DMSO : 24 mg/mL (16.15 mM; Need ultrasonic and warming)

配制儲(chǔ)備液
濃度溶劑體積質(zhì)量1 mg5 mg10 mg
1 mM0.6731 mL3.3654 mL6.7308 mL
5 mM0.1346 mL0.6731 mL1.3462 mL
10 mM0.0673 mL0.3365 mL0.6731 mL
*

請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)月內(nèi)使用,-20°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)月內(nèi)使用。

In Vivo:

以下溶解方案都請(qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑:

——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶

  • 1.


    請(qǐng)依序添加每種溶劑: PBS

    Solubility: 130 mg/mL (87.50 mM); Clear solution; Need ultrasonic


  • 2.


    請(qǐng)依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.08 mg/mL (1.40 mM); Clear solution


  • 3.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (1.40 mM); Clear solution


  • 4.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% corn oil

    Solubility: ≥ 2.08 mg/mL (1.40 mM); Clear solution


參考文獻(xiàn)

[1]. Rybak MJ, et al. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S35-9.

[2]. Watanakunakorn C, et al. Mode of action and in-vitro activity of vancomycin. J Antimicrob Chemother. 1984 Dec;14 Suppl D:7-18.

[3]. Warren CA, et al. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice. Antimicrob Agents Chemother. 2013 Feb;57(2):689-96.



Vancomycin hydrochloride (鹽酸萬(wàn)古霉素)

Vancomycin hydrochloride (鹽酸萬(wàn)古霉素)

分享到微信

×
Vancomycin hydrochloride 是用于研究細(xì)菌感染 (bacterial) 的抗生素。 它通過(guò)抑制易感細(xì)菌的細(xì)胞壁合成的第二階段起作用。 Vancomycin hydrochloride 還改變細(xì)胞膜的滲透性并選擇性地抑制核糖核酸的合成。貨號(hào):HY-17362 ,CAS:1404-93-9
品牌:MCE
型號(hào):HY-17362
起訂量:1
規(guī)格::250 mg
價(jià)格::¥500
15906629305
在線客服
產(chǎn)品詳情

Vancomycin hydrochloride (Synonyms: 鹽酸萬(wàn)古霉素)

Vancomycin hydrochloride 是用于研究細(xì)菌gan染 (bacterial) 的抗生su。 它通過(guò)抑制易感細(xì)菌的細(xì)胞壁合成的第二階段起作用。 Vancomycin hydrochloride 還改變細(xì)胞膜的滲透性并選擇性地抑制核糖核酸的合成。

生物活性

Vancomycin hydrochloride is an antibiotic for the treatment of bacterial infections. It acts by inhibiting the second stage of cell wall synthesis of susceptible bacteria. Vancomycin also alters the permeability of the cell membrane and selectively inhibits ribonucleic acid synthesis


IC50 & Target:Bacterial[1]


體外研究(In Vitro)

Vancomycin is a large glycopeptide compound with a molecular weight of 1450 Da[1]. Vancomycin is a unique glycopeptide structurally unrelated to any currently available antibiotic. It also has a unique mode of action inhibiting the second stage of cell wall synthesis of susceptible bacteria. Vancomycin is active against a large number of species of Gram-positive bacteria, such as Staphylococcus aureus, Staph. epidermidis, Str. agalactiae, Str. bovis, Str. mutans, viridans streptococci, enterococ


體內(nèi)研究(In Vivo)

Vancomycin is administered intravenously, with a standard infusion time of at least 1 h, to minimize infusion-related adverse effects. Subjects with normal creatinine clearance, vancomycin has an α-distribution phase of 30 min to 1 h and a β-elimination half-life of 6-12 h. The volume of distribution is 0.4–1 L/kg. The binding of vancomycin to protein ranges from 10% to 50%. Factors that affect the overall activity of vancomycin include its tissue distribution, inoculum size, and protein-binding effects[1]. Vancomycin treatment of infected mice is associated with improved clinical, diarrhea, and histopathology scores and survival during treatment[3].


分子量:1485.71


Formula:C66H76Cl3N9O24


CAS 號(hào):1404-93-9


中文名稱:鹽酸萬(wàn)古霉素


來(lái)源:Streptomyces orientalis


運(yùn)輸條件:Room temperature in continental US; may vary elsewhere.


儲(chǔ)存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


溶解性數(shù)據(jù)


H2O : 33.33 mg/mL (22.43 mM; Need ultrasonic)

DMSO : 24 mg/mL (16.15 mM; Need ultrasonic and warming)

配制儲(chǔ)備液
濃度溶劑體積質(zhì)量1 mg5 mg10 mg
1 mM0.6731 mL3.3654 mL6.7308 mL
5 mM0.1346 mL0.6731 mL1.3462 mL
10 mM0.0673 mL0.3365 mL0.6731 mL
*

請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)月內(nèi)使用,-20°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)月內(nèi)使用。

In Vivo:

以下溶解方案都請(qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑:

——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶

  • 1.


    請(qǐng)依序添加每種溶劑: PBS

    Solubility: 130 mg/mL (87.50 mM); Clear solution; Need ultrasonic


  • 2.


    請(qǐng)依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.08 mg/mL (1.40 mM); Clear solution


  • 3.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (1.40 mM); Clear solution


  • 4.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% corn oil

    Solubility: ≥ 2.08 mg/mL (1.40 mM); Clear solution


參考文獻(xiàn)

[1]. Rybak MJ, et al. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S35-9.

[2]. Watanakunakorn C, et al. Mode of action and in-vitro activity of vancomycin. J Antimicrob Chemother. 1984 Dec;14 Suppl D:7-18.

[3]. Warren CA, et al. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice. Antimicrob Agents Chemother. 2013 Feb;57(2):689-96.



選擇區(qū)號(hào)